Podcasts about Clinical

Join hosts Zach and Kevin for the annual Very Clinical holiday wrap-up! This week, they welcome back the recurring year-end duo, Dr. Erin Elliott and Dr. Gary Holtzclaw. It is officially a tradition as Erin and Gary join the guys to break down how they are spending the holidays and what has changed in their lives over the last twelve months. In this festive episode, the group shares their unique Christmas traditions, ranging from Icelandic rice pudding games to seafood feasts and tongue-in-cheek "virgin sacrifices." Beyond the holiday cheer, they dive into significant life updates. Kevin discusses the transition of selling his practice to become an associate and his growing obsession with pickleball. Erin shares the joys of empty nesting and her quest to visit every NFL stadium. Gary reveals why he deleted his social media accounts to reclaim his attention span and his commitment to taking real vacations, while Zach opens up about the realities of taking over full ownership of his family practice. It is a candid look at the personal and professional evolution of four dentists at different stages of their careers. Join the Very Clinical Facebook group!  Join the Very Dental Facebook Group using one of these passwords: Timmerman, Bioclear, Hornbrook, Gary, McWethy, Papa Randy, or Lipscomb!  The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! I'm a big fan of the Bioclear Method! I think you should give it a try and I've got a great offer to help you get on board! Use the exclusive Very Dental Podcast code VERYDENTAL8TON for 15% OFF your total Bioclear purchase, including Core Anterior and Posterior Four day courses, Black Triangle Certification, and all Bioclear products. Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code "VERYSHIP" you'll get free shipping on your order! Go save yourself some money and support the show all at the same time! The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!

Parenting and addiction are not two words you want in the same sentence, but unfortunately, addiction happens, and thus, parents need to know the facts about it. The Inherited Pattern of Addiction Addiction isn't just about individual choices; it often stems from generational patterns and dysfunction. Many people facing addiction today can trace their struggles back to influences and events in their family history. The interplay of epigenetics and unresolved emotional issues can shape how children are raised and how they handle challenges, impacting their potential for addiction. Recognizing Warning Signs in Children Parents might wonder what the early indicators of their child's potential addiction could be. It's essential to pay attention to changes in behavior, such as shifts in interests, friend groups, or academic performance. Unexplained isolation, carrying certain items everywhere, or noticeable changes in physical appearance can also signal underlying issues. Always trust your instincts; if you suspect something, there's often a valid reason behind it. The Role of Anxiety and Emotional Neglect Balancing Boundaries with Understanding Handling Older Children and Adult Addiction Relapse During the Holiday Season Holidays can amplify stressors, leading to a spike in relapses. Increased pressure, financial strain, and family dynamics can overwhelm someone in recovery. Families can support their loved ones by keeping celebrations manageable and straightforward, and avoiding substances that might trigger a relapse. Planning and open discussions about expectations can alleviate holiday-induced anxiety, helping maintain sobriety. Faith as a Pillar in Recovery About Kim Castro Kim Castro is committed to helping individuals, families, treatment programs, and addiction counselors develop and grow. She utilizes cutting-edge treatment modalities to deliver a gold standard of clinical care. For over a decade, Kim was the Executive Director of Recovery Outfitters, Inc. Kim is a certified master's-level counselor and certified clinical supervisor who instructs counselors seeking or maintaining credentials. She earned a master's degree in Conflict Management and a bachelor's degree in psychology from Kennesaw State University. Kim is recognized as a Subject Matter Expert in the field of addiction, even helping to revise the international master's-level certification for addiction counseling. In addition, she integrates both Faith-based and Clinical approaches to addiction treatment. Website for Kim Castro Read the full show notes and access all links. Additional Resources Download Kim's Guide on Helping vs. Enabling Book Recommendation: Boundaries by Dr. Henry Cloud and Dr. John Townsend

Clinical psychologist, educational leader, and author of Untethered: Creating Connected Families, Schools and Communities to Raise a Resilient Generation, Dr. Doug Bolton, joins me this week to unpack the rising levels of anxiety, burnout, and overwhelm we're seeing in kids today.   Together we explore:   - How changes in education starting in the 90s have intensified academic pressure for kids of all ages. - Why school avoidance, perfectionism, and burnout are rising, even among high-achieving students. - The neuroscience behind why rigor, overscheduling, and constant output make it harder for kids to access curiosity, regulation, and real learning. - How expectations have shifted, and why many kids simply aren't developmentally ready for what schools now demand. - Realistic, achievable ways to build rest, connection, and resilience into daily family life. - Small shifts parents can make at home to buffer their child's stress, protect their mental health, and restore balance.   If your child is melting down after school, anxious about grades, overwhelmed by homework, or feeling weighed down by pressure to perform, this episode will help you understand what's really going on beneath the surface and give you practical tools to support their wellbeing.     LEARN MORE ABOUT MY GUEST:

In this episode, Coach Debbie Potts sits down with Dr. Zulia Frost, Co-Founder and Medical Director of Recharge Health, to explore how targeted red light therapy can support mitochondrial repair, thyroid function, gut health, liver detoxification, and overall metabolic resilience for adults navigating midlife. If you are in your 40s, 50s, 60s, or beyond and want to improve your energy, metabolism, hormone balance, digestion, and recovery, this conversation provides the education, tools, and strategies you need to optimize your health from the inside out. Zulia explains the science behind photobiomodulation, how red and near-infrared light activate cellular energy pathways, and why FlexBeam delivers medical-grade targeted therapy directly to organs and tissues that need it most. We break down the research on mitochondrial function, Hashimoto's and thyroid hormone conversion, gut inflammation, motility challenges, liver congestion, stress recovery, and active aging. This episode is especially relevant for midlife athletes, high performers, over-40 adults experiencing metabolic slowdown, and anyone wanting to age with strength, clarity, and vitality. Mentioned in the Episode FlexBeam by Recharge Health Try FlexBeam and save with code: CoachDebbiePotts Website: https://recharge.health (affiliate support is appreciated) Topics Covered • Why mitochondrial function declines with age and how red light supports ATP production • The connection between photobiomodulation and thyroid hormone activation • Clinical research on PBM for Hashimoto's and autoimmune thyroid dysfunction • Red light therapy for gut inflammation, motility, and microbiome balance • Liver detoxification, metabolic health, and targeted PBM application • Supporting the nervous system, vagal tone, sleep quality, and stress recovery • FlexBeam protocols for midlife athletes and active aging • How to integrate daily PBM routines into lifestyle, training, and recovery • Why targeted photobiomodulation works differently from full-body light panels About Zulia Frost Dr. Zulia Frost is a pioneer in photobiomodulation, neuromuscular rehabilitation, and integrative medicine. With more than two decades of clinical experience, she is internationally recognized for her work in cellular repair technologies and her scientific leadership at Recharge Health. Connect with Coach Debbie Potts Website: https://www.debbiepotts.net Podcast: The Coach Debbie Potts Show YouTube: https://www.youtube.com/@coachdebbiepotts Instagram: @coachdebbiepotts Email: coachdebbiepotts@icloud.com Support the Show If this episode helped you understand how to age stronger instead of slower, please rate, review, and share it with someone looking to improve their health, metabolism, and longevity.

In this episode, Nathan A. Merriman, MD, MSCE, Interim Senior Medical Director of Surgical Specialties for the Digestive Health Clinical Program at Intermountain Medical Center, discusses how a patient-centered, team-based approach can improve access to care while enhancing the overall human experience. He shares insights on driving operational efficiency across surgical services and aligning clinical teams to deliver high-quality, coordinated care that meets patients where they are.

In this episode of the MaternalRX podcast on the Pharmacy Podcast Network, Danielle sits down with Dr. Tadeh Vartanian, a Pharmacist and Medical Lead with deep expertise in autoimmune diabetes. Drawing on years of clinical practice and research, Dr. Vartanian explains why early detection and precise diabetes classification can dramatically shift outcomes for people who are pregnant, planning pregnancy, or managing complex metabolic risks. This conversation delivers a practical, up-to-date overview of diabetes types, maternal risk considerations, screening strategies, and the emerging science behind autoimmune and genetic diabetes. And if you have never heard of monogenic diabetes, you will want to hear this episode! Understanding this category can immediately change how clinicians diagnose and treat patients. Diabetes types explained - How to differentiate type 1 diabetes, type 2 diabetes, gestational diabetes, and monogenic diabetes - Why type 1 is autoimmune and what loss of 80 to 90 percent of beta cells means for patient management - The phases of type 1 diabetes and the predictive power of autoantibodies - How monogenic diabetes presents differently and when to consider genetic testing - Which diabetes types can improve with targeted lifestyle interventions Diabetes screening and diagnostic testing - Why early screening is the most impactful action clinicians can take - When to use hemoglobin A1C, fasting glucose, and the oral glucose tolerance test - A clear explanation of the 50-gram and 100-gram Glucola tests used in gestational diabetes screening and diagnosis - How to identify autoimmune diabetes using autoantibody testing Autoantibody screening programs - TrialNet: the NIDDK-supported program offering at-home screening for people with a first-degree relative with type 1 diabetes - ASK (Autoimmunity Screening for Kids): now expanded to adults, with nationwide access through the University of Colorado laboratory - How these programs detect autoimmune diabetes before symptoms develop Genetics, autoimmunity, and diabetes research - How new genetic testing is reshaping the identification of monogenic diabetes - What autoimmune activity means in type 1 diabetes and why early detection matters - Current research, evolving guidelines, and clinical trial insights relevant to maternal health and diabetes care Diabetes and pregnancy - How diabetes influences pregnancy outcomes and why classification accuracy is critical - The long-term significance of gestational diabetes and its link to future type 2 diabetes - Clinical considerations for preconception counseling, prenatal care, and postpartum metabolic health - How maternal diabetes affects the long-term health trajectory of both parent and child Key takeaway from Dr. Vartanian: Screen early and use the right tools. Identifying diabetes risk before symptoms appear can change the course of care at every stage of pregnancy. Connect with our guest and host: - Dr. Tadeh Vartanian: www.linkedin.com/in/tadehvartanian/ - Dr. Danielle Plummer: www.linkedin.com/in/daniellerplummer/

In this episode, Anthony J. Tortolani, MD, FACS, FACC, Cardiac and Thoracic Surgeon and Professor Emeritus of Clinical Cardiothoracic Surgery at Weill Cornell Medical College, discusses the realities of declining profit margins and how leaders are balancing financial pressures with clinical excellence. He explores practical applications of AI in clinical medicine, including improvements in efficiency and less invasive surgical approaches, and shares why aligning strategic vision with day-to-day tactical planning is essential for long-term success in cardiovascular care.

Each year on TheBodyPro, David Alain Wohl, M.D., of the University of North Carolina summarizes and analyzes the 10 new studies and noteworthy events that he feels are most likely to have a palpable impact on the way we approach HIV prevention, treatment, and patient care in the U.S. And each year on this podcast, we welcome Dr. Wohl for a discussion about these keystone moments and their import.   Read the transcript: https://www.thebodypro.com/podcast/hiv/future-hiv-care-top-10-david-wohl-dec-2025   Peruse Dr. Wohl's picks: https://www.thebodypro.com/collection/top-10-2025-hiv-clinical-developments   This podcast is hosted and executively produced by Myles Helfand, TheBodyPro's executive editor; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema.

Welcome to "Labor & Delivery Debrief," the podcast where we tackle your toughest questions about childbirth and maternal health. Today, we're diving deep into a fascinating and critical topic sent in by one of our listeners, Sarah. Sarah asks: "Is it possible for a clinical diagnosis of chorioamnionitis to not be confirmed by placental histology? And if so, how is that possible?" This is a fantastic question that touches on the complexities of intrapartum clinical diagnosis of intraamniotic infection (IAI), also commonly known as chorioamnionitis. We'll explore the nuances of clinical versus histological findings, the diagnostic criteria, and why these two assessments don't always perfectly align. Get ready for a detailed discussion that will shed light on this important aspect of obstetric care.1. ACOG CO 712; 2017 (2025)2. Romero R, Pacora P, Kusanovic JP, et al. Clinical Chorioamnionitis at Term X: Microbiology, Clinical Signs, Placental Pathology, and Neonatal Bacteremia - Implications for Clinical Care. Journal of Perinatal Medicine. 2021;49(3):275-298. doi:10.1515/jpm-2020-0297.3. Jung E, Romero R, Suksai M, et al. Clinical Chorioamnionitis at Term: Definition, Pathogenesis, Microbiology, Diagnosis, and Treatment. AJOG. 2024;230(3S):S807-S840. doi:10.1016/j.ajog.2023.02.002.4. Oh KJ, Kim SM, Hong JS, et al. Twenty-Four Percent of Patients With Clinical Chorioamnionitis in Preterm Gestations Have No Evidence Of either Culture-Proven Intraamniotic Infection Or intraamniotic Inflammation. AJOG. 2017;216(6):604.e1-604.e11.

In this episode, Hallie Bulkin speaks with Dr. Alyssa Welch about the vital role of interprofessional collaboration in achieving optimal patient outcomes, particularly for speech-language pathologists (SLPs). Dr. Welch emphasizes that working alongside occupational therapists (OTs), physical therapists (PTs), dentists, and other specialists is not just beneficial—it is now a core competency in modern healthcare.Dr. Welch and Hallie discuss the necessity of recognizing the limits of your own expertise and knowing when to make a referral. Collaboration ensures a whole-person therapeutic approach and prevents the professional burnout that comes from trying to "fix everything" in isolation. They cover key areas where SLPs and other therapists must coordinate care, such as feeding mechanics, positioning for speech, and addressing core stability and motor skills.In this episode, you'll learn:✔️ ️ Interprofessional collaboration is essential for SLPs, leading to better patient outcomes and reduced medical errors.✔️ Collaboration often involves partnering with Occupational Therapists (OTs) for fine motor skills, positioning, and feeding mechanics, and Physical Therapists (PTs) for gross motor skills, body positioning, and trunk control.✔️ Collaboration shifts the focus from checking off individual treatment boxes to a patient-centered approach that meets the family's actual needs.✔️ Poor communication is responsible for an estimated 70-80% of serious medical errors; collaboration significantly reduces this risk.✔️ Recognizing the limits of your own scope and knowing when to refer is crucial for long-term career sustainability and preventing professional burnout.✔️ Clinical collaboration can take many forms, including email consultations, case conferences, co-treatment sessions, and shared documentation.RELATED EPISODES YOU MIGHT LOVEEpisode 234: The Role of Occupational Therapists in TOTs Care with Anna Dearman MBA, MOT, LOTR, CLCEp 332: The Interconnectedness of Oral and Systemic Health with Amber White RDH, HHPOTHER WAYS TO CONNECT & LEARN

Welcome to the latest episode of L.I.F.T.S, your bite‑sized dose of the Latest Industry Fitness Trends and Stories. In this episode, hosts Matthew Januszek and Mohammed Iqbal sit down with Mohit Kumar, Co‑Founder and CEO of Ultrahuman, to explore the explosive rise of smart rings and the future of wearable health technology. Topics covered include: Mohit's unconventional founder journey and early days in metabolic health. Why smart rings are outperforming other wearables in growth. Ultrahuman's approach to sleep, metabolism, and biomarkers. The high‑stakes patent battle with Oura and the U.S. import ban. What resilience really looks like for founders. The future of AI, battery life, and ring‑based health tracking. Why sleep is becoming the most important performance metric.

In this episode, Anthony J. Tortolani, MD, FACS, FACC, Cardiac and Thoracic Surgeon and Professor Emeritus of Clinical Cardiothoracic Surgery at Weill Cornell Medical College, discusses the realities of declining profit margins and how leaders are balancing financial pressures with clinical excellence. He explores practical applications of AI in clinical medicine, including improvements in efficiency and less invasive surgical approaches, and shares why aligning strategic vision with day-to-day tactical planning is essential for long-term success in cardiovascular care.

In this episode, Anthony J. Tortolani, MD, FACS, FACC, Cardiac and Thoracic Surgeon and Professor Emeritus of Clinical Cardiothoracic Surgery at Weill Cornell Medical College, discusses the realities of declining profit margins and how leaders are balancing financial pressures with clinical excellence. He explores practical applications of AI in clinical medicine, including improvements in efficiency and less invasive surgical approaches, and shares why aligning strategic vision with day-to-day tactical planning is essential for long-term success in cardiovascular care.

In his weekly clinical update, Dr. Griffin and Vincent Racaniello protest Vinjay Prasad, head of CBER FDA Nov memo stating administration of the COVID-19 vaccine resulted in 10 children's deaths, but are cautiously delighted by the December memo from those in CBER who dispute this data-less claim, how in 31 states pertussis vaccination rates have declined before Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, of clinical outcomes of oseltamivir versus baloxavir for treating influenza infection, number deaths associated with COVID-19 hospitalizations and disease associated economic burden, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, how the German government is committed to research into long COVID and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Industry laments Prasad vaccine memo (Politico) Scoop: FDA vaccine chief's memo cited 10 pediatric Covid-19 vaccine deaths—but the agency's own analysis found 0–7 (Inside Medicine) Whooping cough cases soar as vaccination rates drop (NBC News) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Hundreds quarantined as South Carolina measles outbreak accelerates (Washington Post) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) In call with clinicians, CDC recommends flu vaccines widely (CIDRAP) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) Comparison of clinical outcomes of oseltamivir versus baloxavir in outpatients with influenza: a retrospective cohort analysis (International Journal of Infectious Diseases) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of 2024–2025 COVID-19 Vaccines in Children in the United States — VISION, August 29, 2024–September 2, 2025 (CDC:MMWR) Mortality following recovery from COVID-19 hospitalization: A long-term cohort study (International Journal of Infectious Diseases) COVID hospitalization tied to 69% higher risk of death for up to 2 years (CIDRAP) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavir (Journal of Medical Economics) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long-COVID research just got a big funding boost: will it find new treatments?(Nature) Reaching out to US house representative Letters read on TWiV 1280 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Pharmacists can be essential in managing myasthenia gravis by providing education, identifying exacerbating medications, offering therapeutic alternatives, and supporting overall appropriate pharmacotherapy. This podcast provides pharmacists with an understanding of the pathophysiology of myasthenia gravis and myasthenic crisis, common complications associated with the disease state, and useful medication management considerations for the emergency department setting. CE for this episode expires on December 20, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Send us a textA small structural “bump” on a molecule might be the big breakthrough EPM care has been waiting for. We sit down with researcher and clinician Izabela de Assis Rocha to unpack how bumped kinase inhibitors exploit a tiny difference between parasite and mammalian kinases to hit Sarcocystis neurona where it hurts—motility, invasion, and replication—while sparing the horse. It's a molecular strategy with practical promise, and the conversation bridges the stall, the lab, and the future of equine neurology.We break down the science behind CDPK1, the gatekeeper residue that drives selectivity, and why unique parasite structures like the apical complex and apicoplast open new therapeutic lanes. Then we move into what really matters for care: pharmacokinetics and clinical fit. BKI-1708 shows strong systemic distribution that positions it as a prophylactic candidate, while early data on BKI-1553 suggests better CNS penetration and a path toward active EPM treatment. Isabella explains how EPM's dead-end host biology may lower the risk of widespread resistance, a rare bright spot in the antiparasitic landscape.Clinical trials are the hard part. With no robust experimental infection model and fewer than 1% of exposed horses developing disease, enrolling enough cases takes patience and teamwork. We talk about building pragmatic, clinician-led studies, harmonizing diagnostics and neurologic scoring, and tracking relapse to find outcomes that matter to horses and owners. The One Health angle also shines through: BKIs show activity against equine piroplasmosis and have potential roles in toxoplasmosis and cryptosporidiosis, linking equine research to human and livestock health.If you care about evidence-based equine neurology, new antiparasitic strategies, and turning elegant biochemistry into barn-side change, this is your roadmap. Subscribe, share with a colleague who manages EPM cases, and leave a review to help more veterinarians find the show. What question would you ask about bringing BKIs into practice?AJVR article: https://doi.org/10.2460/ajvr.25.07.0270INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ? JAVMA ® : https://avma.org/JAVMAAuthors AJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® : Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook Instagram: JAVMA (@avma_javma) • Instagram photos and videos Twitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | Facebook Instagram: AJVR (@ajvroa) • Instagram photos and videos Twitter: AJVR (@AJVROA) / Twitter JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

An overview of what is a hiatus hernia (including sliding & paraesophageal classification), the causes of a hiatus hernia as well as the most common signs and symptoms. Also includes diagnosis and treatment of hiatus hernia. PDFs available here: https://rhesusmedicine.com/pages/gastroenterologyConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Buy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is  Hiatal Hernia0:27 Hiatal Hernia Causes / Pathophysiology1:09 Hiatal Hernia Symptoms2:05 Epidemiology (Who gets a Hiatal Hernia)2:20 Hiatal Hernia Classification3:09 Hiatal Hernia Diagnosis3:53 Hiatal Hernia TreatmentLINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/ReferenceNational Center for Biotechnology Information (NCBI), 2024. Hiatal hernia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. [online] Available at: https://www.ncbi.nlm.nih.gov/books/NBK562200/. NCBIHyun, J.J., 2011. Clinical significance of hiatal hernia. PMC Articles, PMCID PMC3166665. [online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166665/. PMCEmbleton, D.B. et al., 2018. Congenital hiatus hernia: a case series. PMC Articles, PMCID PMC6593919. [online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593919/. PMCHopkins Medicine, 2022. Hiatal hernia. [online] Available at: https://www.hopkinsmedicine.org/health/conditions-and-diseases/hernias/hiatal-hernia. Hopkins MedicinePatient.info, 2025. Hiatus hernia: symptoms, causes and treatment. [online] Available at: https://patient.info/digestive-health/acid-reflux-and-oesophagitis/hiatus-hernia#nav-5. PatientMSD Manuals, 2025. Hiatus hernia – esophageal and swallowing disorders. [online] Available at: https://www.msdmanuals.com/en-gb/professional/gastrointestinal-disorders/esophageal-and-swallowing-disorders/hiatus-hernia.Disclaimer: Please remember this podcast and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

In this episode, Marcus Perez, President of Altera Digital Health, discusses how trusted, well governed data is the foundation for meaningful AI adoption in healthcare. He shares practical use cases around ambient documentation, workflow improvement, value based care, and why AI driven progress must evolve at the pace of clinicians and organizations.This episode is sponsored by Altera Digital Health.

In a wide-ranging, high-octane interview, Hall of Famer Rick Pitino joins Brandon Tierney to discuss the state of St. John's basketball and his storied career. Pitino gets brutally honest about his current squad, admitting they lack the veteran dominance of last year's team and issuing a public challenge to Bryce Hopkins to become an "alpha dog" or risk his NBA dreams. The conversation turns fiery and nostalgic as Pitino recounts a "hysterical" story from the birth of WFAN, remembering how "clinical moron" callers wanted him fired while his Knicks were in first place. The Coach also settles New York's greatest debates, naming Pearl Washington and Kenny Anderson as the ultimate handles and Chris Mullin as the city's premier marksman. To wrap it up, BT shares a legendary personal story of an all-night bar session with Pitino that felt like a scene straight out of The Godfather.

This week on Curious Now, we're joined by an expert in the exploration phase of debriefing to help us better understand the “listen and explore” region of PAAIL. Bridget Van Gotten is a Learning and Design Strategist for the Zamierowski Institute for Experiential Learning at Kansas University Medical Center, and a 2015 alum of the CMS Healthcare Simulation Essentials: Design & Debriefing course. The KUMC team designed a new approach to exploration when they found that in simulation, learners were simply agreeing with the debriefer's point of view rather than trying to contrast it with their own thoughts, especially when they were doing the right thing (i.e. “I did the correct thing because that's the correct thing to do.”) A second major discovery was that learners at all experience levels were describing the same barriers to success, rather than having different needs at different levels. For example, both med students and attendings might describe the busyness of the code space as making it difficult to claim a leadership role during the case, often using the exact same words. Bridget coaches Jenny on how to conduct better explorations of learner thinking, in this case in a faculty development conversation about classroom management and maintaining the attention of learners. #healthcaresimulation #nursing #medicine #debriefing Spotify: https://open.spotify.com/show/72gzzWGegiXd9i2G6UJ0kP Apple Podcasts: https://podcasts.apple.com/us/podcast/the-center-for-medical-simulation/id1279266822 Leadership Coaching from Jenny Rudolph: https://harvardmedsim.org/personal-leadership-coaching-with-jenny-rudolph/

Treatment-resistant depression (TRD) is a considerable clinical challenge. Esketamine, in conjunction with an oral antidepressant, is a potential treatment for TRD. In this podcast, Dr. Matteo Lupi discusses his article, "Esketamine and Quality of Life Improvement in Treatment-Resistant Depression Patients: A Real-World Clinical Study." The prospective study described in the report explores the long-term effects of esketamine therapy on subjective quality of life in adults with TRD.   The other contributing authors are Alessandro Carano, Tiziano Acciavatti, Stefano Marini, Marco Palmucci, Elicio Marinucci, Enrico Paolini, Alessandro Gentile, Angelomarco Barioglio, Marco Giri, Domenico De Berardis, and Giovanni Martinotti. The article is published in the January-February 2026 issue of The Journal of Clinical Psychopharmacology. doi: 10.1097/JCP.0000000000002042

Feeling stuck in depression? Clinical hypnosis is gaining attention as an effective treatment option that works differently than traditional talk-based therapy alone. Go to https://www.nyhealthhypnosis.com/specialties/depression for more information. NY Health Hypnosis & Integrative Therapy City: New York Address: 177 Prince Street Suite 401 Website: https://www.nyhealthhypnosis.com/ Phone: +16465371713 Email: info@nyhealthhypnosis.com

Dr. Gent is an accomplished clinician and expert in psychotherapeutic development with a distinguished career that spans over two decades. He is currently the Chief Clinical Officer at Pacific Quest where he oversees the Clinical program, ensuring the highest standards of care and leading a dedicated team of professionals.In This EpisodeRob's websitePacific Quest on FacebookPacific Quest on YoutubeBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.You can learn more about what I do here:The Trauma Therapist Newsletter: celebrates the people and voices in the mental health profession. And it's free! Check it out here: https://bit.ly/4jGBeSa———If you'd like to support The Trauma Therapist Podcast and the work I do you can do that here with a monthly donation of $5, $7, or $10: Donate to The Trauma Therapist Podcast.Click here to join my email list and receive podcast updates and other news.Thank you to our Sponsors:Incogni - Use code [traumatherapist] and get 60% off annual plans: https://incogni.com/traumatherapistJane App - use code GUY1MO at https://jane.app/book_a_demoJourney Clinical - visit https://join.journeyclinical/trauma for 1 month off your membershipTherapy Wisdom - https://therapywisdom.com/jan/

[We weren’t available to record a new show for you this week, so enjoy this rerun instead!] Clinical students are sometimes the only ones who have time to listen In the clinic, med students can feel like bystanders, but they can make all the difference for patients. M3 Jeff Goddard, M3 Tracy Chen, M2 Alex Nigg, and M4 Matt Engelken recount stories of the patients that stuck with them—some painful, some beautiful, and some just plain awkward. From OB-GYN to peds to the ER, they share how student doctors—who can often feel like tagalongs—can often be the ones offering emotional support, catching critical miscommunications, or just being the one person with time to care. We reflect on the pressure to look competent, the sting of lukewarm evaluations, and how one med student realized a patient wasn't constipated—just heartbroken. Also in this episode: talking to dying patients, babies are scary, and what not to say when to overwhelmed family. Episode credits: Producer: Dave Etler Co-hosts: Matt Engelken, M4; Jeff Goddard, M3; Tracy Chen, M3; Alex Nigg, M2 We Want to Hear From You: YOUR VOICE MATTERS! We welcome your feedback, listener questions, and shower thoughts. Do you agree or disagree with something we said today? Did you hear something really helpful? Can we answer a question for you? Are we delivering a podcast you want to keep listening to? Let us know at https://theshortcoat.com/tellus and we'll put your message in a future episode. Or email theshortcoats@gmail.com. The Short Coat Podcast is FeedSpot’s Top Iowa Student Podcast, and its Top Iowa Medical Podcast! Thanks for listening! We do more things on… Instagram: https://www.instagram.com/theshortcoat YouTube: https://www.youtube.com/theshortcoat You deserve to be happy and healthy. If you’re struggling with racism, harassment, hate, your mental health, or some other crisis, visit http://theshortcoat.com/help, and send additions to the resources there to theshortcoats@gmail.com. We love you. Music provided by Argofox. License: bit.ly/CCAttributionDOCTOR VOX – Heatstroke: youtu.be/j1n1zlxzyRE Catmosphere – Candy-Coloured Sky: youtu.be/AZjYZ8Kjgs8Hexalyte – Wandering Hours: youtu.be/FOAo2zsYnvA

Dr. Sausha Toghranegar takes a deep dive into osseodensification and its role in crestal sinus lifts. He breaks down the evolution and design of osseodensification drills, addresses common controversies, and shares practical techniques for improving implant outcomes. Through a detailed case study, Dr. Toghranegar highlights the importance of understanding bone density, healing dynamics, and proper surgical execution. The episode wraps with insight into emerging learning opportunities and what's next in this advancing area of dental surgery.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent news updates and key advancements shaping the industry in 2025.Staying healthy during the holidays (00:18): Discover how to protect yourself and others as a new influenza strain, holiday gatherings, and increased travel raise the risk of spreading viruses. 2025 breakthroughs and trends (04:31): Learn more about the technologies, regulations, and innovation influencing the future of clinical diagnostics. Note: Information in this post was accurate at the time of its posting.Resources"Answers From the Lab” podcast: Innovations Set to Shape the Industry in 2025Dr. Morice shares trends and predictions for 2025Mayo Clinic Minute: How to prepare for the influenza seasonMayo Clinic Minute: Wash your hands for better healthVaccines and viruses: Protecting health across generations

The last clinical corner article of 2025! Matt and Allie are back to discuss this month's article about a familiar topic: Prehab! This specific article is a literature review that gathers information from thousands of cases and reports covering controlled trials that compared treatments for total hip and total knee surgeries. Matt poses his monthly question to PT students listening, and describes the findings in the article. Read the article here: https://www.jospt.org/doi/10.2519/jospt.2025.13075Are you a current/past patient tuning in from the link in your email? Leave a comment on our socials and share this with a friend! Have a question or are looking to start prehab for yourself? Contact us here: https://www.oxfordphysicaltherapy.com/ask-a-questionDid you know that you don't need a doctor's prescription to receive physical therapy? The laws of Direct Access allow you to receive physical therapy without a referral and still use your insurance benefits! Learn more on how Direct Access can help YOU! Our website: https://www.oxfordphysicaltherapy.com/

In this episode of Admissions Straight Talk, host Dr. Valerie Wherley sits down with Dr. Reynold Jaglal, program director of the Sacred Heart University Master of Science in Physician Assistant Studies (MSPAS) program, for an in-depth look at Sacred Heart's values-focused approach to physician assistant (PA) education. Dr. Jaglal breaks down the program's 27-month curriculum, including its team-taught didactic model, hands-on clinical rotations, and distinctive international clinical opportunities in Ireland and Spain.He also shares what makes Sacred Heart's primary care–focused training unique, such as its required orthopedics rotation, and provides clear, practical advice for PA school applicants on demonstrating their fit with the school's mission, communicating their personal values, and explaining their academic challenges. Whether you're preparing to apply, exploring clinical programs, or curious about global PA education, this episode offers a thoughtful, insider perspective.00:00 Welcome to the Admissions Straight Talk podcast00:35 Welcome our guest, Dr. Reynold Jaglal00:55 The PA program at Sacred Heart University02:07 PA program curriculum and faculty06:01 International training opportunities09:15 Clinical phase12:41 Dual degree: Bachelor's-MS in Physician Assistant Studies (BS-MSPAS)15:42 Growing interest in the PA degree17:35 How to create a competitive PA applicationRelated Resources:Dr. Reynold Jaglal contact informationSacred Heart University Master of Science in Physician Assistant StudiesSacred Heart University Bachelor's–MS in Physician Assistant StudiesThe Ultimate Guide to Becoming a Physician Assistant, a free Accepted guide Related Admissions Straight Talk EpisodesHow to Get Accepted to Duke's Physician Assistant Program [Episode 591]How to Get into Physician Assistant Programs [Episode 515]Inside the Emory PA Program: Admissions, Curriculum, and Keys to Success [Episode 603] Follow UsYouTubeFacebookLinkedInContact Uswww.accepted.comsupport@accepted.com+1 (310) 815-9553

It's not quite done yet but it's not far off. Phil and Yas on the second day at the Adelaide Oval.

I keep hearing people argue about whether recovery should be clinical or spiritual, and honestly, that argument misses the point. Alcoholism doesn't live in just one part of us. It messes with our thinking, our emotions, our behavior, and our spirit. So why would recovery only address one of those? Clinical tools help me understand my patterns, my trauma, and my reactions. Spiritual principles help me surrender what I can't control and stay grounded when life gets hard. I don't have to choose between the two — I need both. When recovery is only clinical, it turns into self-management. When it's only spiritual, it can turn into denial. The work happens in the overlap — where I take responsibility, ask for help, and rely on something bigger than me. Recovery isn't clinical or spiritual. It's both. And when we stop arguing about sides, people actually get better.”

Today's guests are Okemena Ewoterai, BSN, MA, CCDS, CDIP, CCS, director of CDI at Montefiore Medical Center in the Bronx, New York, and Trey La Charité, MD, FACP, SFHM, CCS, CCDS, medical director for CDI and coding at the University of Tennessee Medical Center in Knoxville, Tennessee. Our intro and outro music for the ACDIS Podcast is “medianoche” by Dee Yan-Kay and our ad music is “Take Me Higher” by Jahzzar, both obtained from the Free Music Archive. Have questions about today's show or ideas for a future episode? Contact the ACDIS team at info@acdis.org. Want to submit a question for a future "listener questions" episode? Fill out this brief form!  CEU info: Each ACDIS Podcast episode offers 0.5 ACDIS CEU which can be used toward recertifying your CCDS or CCDS-O credential for those who listen to the show in the first four days from the time of publication. To receive your 0.5 CEU, go to the show page on acdis.org, by clicking on the “ACDIS Podcast” link located under the “Free Resources” tab. To take the evaluation, click the most recent episode from the list on the podcast homepage, view the podcast recording at the bottom of that show page, and click the live link at the very end after the music has ended. Your certificate will be automatically emailed to you upon submitting the brief evaluation. (Note: If you are listening via a podcast app, click this link to go directly to the show page on acdis.org: https://acdis.org/acdis-podcast/advisory-board-series-clinical-validation-denials) Note: To ensure your certificate reaches you and does not get trapped in your organization's spam filters, please use a personal email address when completing the CEU evaluation form. The cut-off for today's episode CEU is Sunday, December 21, at 11:00 p.m. Eastern. After that point, the CEU period will close, and you will not be eligible for the 0.5 CEU for this week's episode. Today's sponsor: Today's show is brought to you by the 2026 ACDIS Pocket Guide, available to order today! Learn more by clicking here: https://bit.ly/3V1Z0gQ ACDIS update: Reminder that the ACDIS offices will be closed for the holidays December 24 through January 2! Apply to speak at the 2026 Revenue Integrity Symposium by January 12, 2026! (http://bit.ly/48YYSVT) Apply to speak at the AHIMA 2026 conference by January 26, 2026! (https://bit.ly/3MAIsvq)  

Chad and Nikki welcome back special guest Natasha Daniels, Anxiety and OCD Child Therapist https://childocdtherapist.com/ for a conversation about Caregiver Fatigue, something many people caring for children or other family members experiencing mental health concerns may experience. Clinical and personal perspectives are shared along with self-care strategies for caregivers.

Synopsis: This episode is proudly sponsored by Quartzy. Roivant Sciences CEO Matt Gline returns to Biotech 2050 for a deeply reflective conversation with host Rahul Chaturvedi on what it really takes to build a biotech company that lasts. From Roivant's transformational $7B Pfizer-to-Roche deal to delivering registrational Phase 3 data in dermatomyositis—one of biotech's most difficult graveyard indications—Matt shares how disciplined execution, decentralization, and learning from failure shaped Roivant's trajectory. The discussion explores Roivant's unique “Vant” model, why multiple CEOs can outperform centralized command-and-control structures, and how thoughtful clinical trial design—down to steroid tapering and site execution—can make or break outcomes in rare disease development. Beyond science and strategy, Matt reflects candidly on his own evolution as CEO, the realities of leading a public biotech through volatile markets, and why authenticity, focus, and embracing hard lessons matter more than chasing hype. This episode is a masterclass in biotech leadership, clinical development, and long-term value creation. Biography: Matt Gline serves as Chief Executive Officer of Roivant Sciences. Mr. Gline joined Roivant in March 2016 and previously served as Chief Financial Officer. From April 2014 to March 2016, he was a Vice President at Goldman Sachs, Fixed Income Digital Structuring, where he focused on technology and data strategy. Prior to Goldman Sachs, Mr. Gline was a co-founder of Fourthree, a risk analytics technology and consulting company. From 2008 to 2012, he served as Vice President at Barclays, Enterprise Risk Management Advisory, where he provided analysis for corporate clients related to capital markets access for financing and risk management. Mr. Gline earned his A.B. in Physics from Harvard College.

Send us a textIn this episode of The Mental Health Business Mentor, we explore what happens when therapists move beyond working in isolation and start building true community with one another. Our guest, Nick Bognar, MFT, shares why authentic, nourishing relationships among clinicians aren't just nice to have—they're essential for sustaining our work, preventing burnout, and ensuring clients receive the best care possible. We discuss how welcoming peers, sharing resources, and offering genuine support can strengthen individual practices while uplifting the entire mental health field. Whether you're a solo practitioner or part of a larger organization, this conversation will inspire you to cultivate connections that make the work more sustainable, meaningful, and deeply human.What You'll Learn:Why therapists benefit personally and professionally from building authentic connections with colleaguesPractical ways to cultivate meaningful professional relationships, even if you're a solo practitionerHow sharing resources, referrals, and wisdom strengthens both individual practices and the broader mental health communitySmall, intentional shifts therapists can make to create more welcoming, supportive spaces for one anotherBio:Nick Bognar is a Licensed Marriage and Family Therapist and the founder of Nick Bognar Coaching, LLC. Based in Pasadena, CA, he owns a thriving private practice with five associates and specializes in men's mental health and codependency. Much of his clinical work centers on helping clients set healthy boundaries and step out of limiting relationship patterns. In addition to his therapy practice, Nick is the creator of Action Practice Building, a coaching program and digital course designed to help therapists grow sustainable, relationship-based, values-driven private practices. Drawing on his experience across business, hospitality, and therapy, Nick teaches clinicians how to build their caseloads through authentic, nourishing professional relationships—without relying on hustle or gimmicks. Nick's work has been featured in NPR, The New York Times, Medium, and other outlets. Whether in the therapy room, through his coaching programs, or as a media contributor, he is passionate about helping people live fuller lives, strengthen their relationships, and grow practices that align with their deepest values.Connect with Nick Bognar:http://www.nickbognartherapy.com/https://www.facebook.com/NickBognarTherapy/https://www.linkedin.com/in/nick-bognar-bb2692371/Dr. Margo Jacquot is the award-winning founder and Chief Care Officer of The Juniper Center, one of the largest woman-owned counseling and therapy practices in the Chicago area. With over 20 years of experience, she specializes in trauma recovery, addiction treatment, and LGBTQ-affirming therapy. Dr. Jacquot is also the host of the "Mental Health Business Mentor" podcast, where she shares insights on running a successful mental health practice. thejunipercenter.com Connect with Dr. Margo Jacquot: Website: thejunipercenter.com Instagram: @thejunipercenter Facebook: The Juniper Center

BUFFALO, NY - December 17, 2025 – A new #research paper was #published in Oncotarget (Volume 16) on December 15, 2025, titled “Machine learning-based survival prediction in colorectal cancer combining clinical and biological features.” In this study, led by Lucas M. Vieira from the University of Brasília and the University of California San Diego, researchers used machine learning to predict survival in patients with colorectal cancer. They built a model by combining biological markers with clinical data. This approach could help improve prognosis and guide treatment strategies for one of the world's most common and deadly cancers. The team analyzed data from over 500 patients, using clinical details such as age, chemotherapy status, and cancer stage, along with molecular features like gene expression and microRNAs. Their goal was to improve how clinicians identify high-risk patients and make outcome predictions more precise. Researchers evaluated three different patient data scenarios using different machine learning techniques. The best-performing was an adaptive boosting model, which achieved 89.58% accuracy. This approach showed that integrating clinical and biological data led to significantly better predictions than using either data type alone. Among the biological markers, the gene E2F8 was consistently influential in all patient groups and is known to play a role in tumor growth. Other important markers included WDR77 and hsa-miR-495-3p, which are also associated with cancer development. Key clinical predictors included cancer stage, patient age, lymph node involvement, and whether chemotherapy was administered. “The proposed method combines biological and clinical features to predict patient survival, using as input data from patients from the United States, available in the TCGA database.” Unlike earlier models that relied on either clinical or molecular data alone, this study demonstrates the added value of combining both. Ensemble methods, which merge multiple learning algorithms, provided more stable and consistent results across all patient groups tested. These research findings could lead to new tools that help clinicians better predict how a patient's disease might progress or respond to treatment. The study also highlights the importance of collecting complete clinical information, such as lifestyle factors, which were missing from the dataset but could enhance future predictions. Overall, the study demonstrated how machine learning can support more accurate and personalized survival predictions in colorectal cancer. It also points to potential future research on markers like E2F8, which may be useful for monitoring or targeted therapy. DOI - https://doi.org/10.18632/oncotarget.28783 Correspondence to - Lucas M. Vieira - lvieira@health.ucsd.edu Abstract video - https://www.youtube.com/watch?v=cy7UL5ZUKuI Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28783 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, colorectal cancer, machine learning, feature selection, non-coding RNAs, genes To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us on social media: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

In this episode of The Cardiac Recovery Room, moderator Vicki Morton, Director of Clinical and Quality Outcomes at Providence Anesthesiology Associates in North Carolina, USA, spoke with Alexander Gregory, a cardiovascular anesthesiologist and assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine, and the Libin Cardiovascular Institute at the Cumming School of Medicine, University of Calgary, Canada, and Dr. V. Seenu Reddy, a cardiothoracic surgeon at HCA's TriStar Cardiovascular Surgery in Nashville, Tennesee, USA, about the 10 things they hate about Enhanced Recovery After Surgery (ERAS).   Chapters 00:00 Introduction  01:38 Overcomplication  05:29 Simple Barriers  08:54 Change Obstructionists  10:52 Status Quo  12:49 Messing with Protocol  14:21 Giving Up on Protocol  16:48 Need for Patient-Reported Outcomes  19:18 Struggle Into Cardiac Subspecialty  21:30 Takeaways  The goal of this discussion was to identify specific challenges and propose potential solutions. They emphasize the importance of having two leaders—a champion and a co-champion—to effectively guide ERAS initiatives. Additionally, they discuss creating standing orders and issues related to microbarriers and resistance to change. They also highlight the need for customization of protocols, acknowledging the differences between surgeons who utilize ERAS and those who do not, as well as the tendency to maintain the status quo. Patient perspectives are another key focus, with a call to implement changes that enhance tracking and monitoring of patient outcomes. Furthermore, they explore the role of technology designed for patients, as well as applying ERAS principles to surgeries that fall “outside of the box.”   The Cardiac Recovery Room is the place to hear the conversations colleagues are having after the meetings. Each month, a new episode will be released featuring a leadership panel from the ERAS Cardiac Society.  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Kevin and Alan are joined again by Dr. Dhaval Patel to discuss the significant shifts occurring in digital dentistry, moving beyond the traditional CEREC workflow. Dhaval explains that his highly popular online group, "Keep CERECing," was recently renamed "Keep CAD/CAMing" after he consulted with Dentsply Sirona's legal team regarding trademark usage, which prompted him to broaden the group's scope. This change has led to a natural expansion in technology focus, now encompassing the wider CAD/CAM landscape including 3D printing and 5-axis milling. Dhaval details how he uses 3D printing for models, surgical guides, and night guards, and leverages a 5-axis mill for larger, multi-unit cases and zirconia restorations, highlighting the cost efficiency and ability to run large jobs overnight. The conversation also explores the rise of dedicated, outsourced digital designers and the potential for artificial intelligence (AI) to handle design in the near future. Some links from the show: Keep CADCAMing Facebook group Dhaval's Instagram Keep CADCAMing website (where you can find information about their upcoming meeting October 15-17th, 2026!) Join the Very Clinical Facebook group!  Join the Very Dental Facebook Group using one of these passwords: Timmerman, Bioclear, Hornbrook, Gary, McWethy, Papa Randy, or Lipscomb!  The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! I'm a big fan of the Bioclear Method! I think you should give it a try and I've got a great offer to help you get on board! Use the exclusive Very Dental Podcast code VERYDENTAL8TON for 15% OFF your total Bioclear purchase, including Core Anterior and Posterior Four day courses, Black Triangle Certification, and all Bioclear products. Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code "VERYSHIP" you'll get free shipping on your order! Go save yourself some money and support the show all at the same time! The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!

Osteomyelitis in children is common enough to miss and serious enough to matter. In this episode of PEM Currents, we review a practical, evidence-based approach to pediatric acute hematogenous osteomyelitis, focusing on diagnostic strategy, imaging decisions including FAST MRI, and modern antibiotic management. Topics include age-based microbiology, empiric and pathogen-directed antibiotic selection with dosing, criteria for early transition to oral therapy, and indications for orthopedic and infectious diseases consultation. Special considerations such as MRSA, Kingella kingae, daycare clustering, and shortened treatment durations are discussed with an emphasis on safe, high-value care. Learning Objectives After listening to this episode, learners will be able to: Identify the key clinical, laboratory, and imaging findings that support the diagnosis of acute hematogenous osteomyelitis in children, including indications for FAST MRI and contrast-enhanced MRI. Select and dose appropriate empiric and pathogen-directed antibiotic regimens for pediatric osteomyelitis based on patient age, illness severity, and local MRSA prevalence, and determine when early transition to oral therapy is appropriate. Determine when consultation with orthopedics and infectious diseases is indicated, and recognize clinical features that warrant prolonged therapy or more conservative management. References Woods CR, Bradley JS, Chatterjee A, et al. Clinical practice guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics. J Pediatric Infect Dis Soc. 2021;10(8):801-844. doi:10.1093/jpids/piab027 Woods CR, Bradley JS, Chatterjee A, et al. Clinical practice guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2023 guideline on diagnosis and management of acute bacterial arthritis in pediatrics. J Pediatric Infect Dis Soc. 2024;13(1):1-59. doi:10.1093/jpids/piad089 Stephan AM, Platt S, Levine DA, et al. A novel risk score to guide the evaluation of acute hematogenous osteomyelitis in children. Pediatrics. 2024;153(1):e2023063153. doi:10.1542/peds.2023-063153 Alhinai Z, Elahi M, Park S, et al. Prediction of adverse outcomes in pediatric acute hematogenous osteomyelitis. Clin Infect Dis. 2020;71(9):e454-e464. doi:10.1093/cid/ciaa211 Burns JD, Upasani VV, Bastrom TP, et al. Age and C-reactive protein associated with improved tissue pathogen identification in children with blood culture-negative osteomyelitis: results from the CORTICES multicenter database. J Pediatr Orthop. 2023;43(8):e603-e607. doi:10.1097/BPO.0000000000002448 Peltola H, Pääkkönen M. Acute osteomyelitis in children. N Engl J Med. 2014;370(4):352-360. doi:10.1056/NEJMra1213956 Transcript This transcript was provided via use of the Descript AI application Welcome to PEM Currents, the Pediatric Emergency Medicine Podcast. As always, I'm your host, Brad Sobolewski, and today we're covering osteomyelitis in children. We're going to talk about diagnosis and imaging, and then spend most of our time where practice variation still exists: antibiotic selection, dosing, duration, and the evidence supporting early transition to oral therapy. We'll also talk about when to involve orthopedics, infectious diseases, and whether daycare outbreaks of osteomyelitis are actually a thing. So what do I mean by pediatric osteomyelitis? In children, osteomyelitis is most commonly acute hematogenous osteomyelitis. That means bacteria seed the bone via the bloodstream. The metaphysis of long bones is particularly vulnerable due to vascular anatomy that favors bacterial deposition. Age matters. In neonates, transphyseal vessels allow infection to cross into joints, increasing the risk of concomitant septic arthritis. In older children, those vessels involute, and infection tends to remain metaphyseal and confined to bone rather than spreading into the joint. For children three months of age and older, empiric therapy must primarily cover Staphylococcus aureus, which remains the dominant pathogen. Other common organisms include group A streptococcus and Streptococcus pneumoniae. In children six to 36 months of age, especially those in daycare, Kingella kingae is an important and often underrecognized pathogen. Kingella infections are typically milder, may present with lower inflammatory markers, and frequently yield negative routine cultures. Kingella is usually susceptible to beta-lactams like cefazolin, but is consistently resistant to vancomycin and often resistant to clindamycin and antistaphylococcal penicillins. This has direct implications for empiric antibiotic selection. Common clinical features of osteomyelitis include fever, localized bone pain, refusal to bear weight, and pain with movement of an adjacent joint. Fever may be absent early, particularly with less virulent organisms like Kingella. A normal white blood cell count does not exclude osteomyelitis. Only about one-third of children present with leukocytosis. CRP and ESR are generally more useful, particularly CRP for monitoring response to therapy. No single CRP cutoff reliably diagnoses or excludes osteomyelitis in children. While CRP is elevated in most cases of acute hematogenous osteomyelitis, the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America note that high-quality data defining diagnostic thresholds are limited. A CRP above 20 milligrams per liter is commonly used to support clinical suspicion, with pooled sensitivity estimates around 80 to 85 percent, but no definitive value mandates the diagnosis. Lower values do not exclude disease, particularly in young children, as CRP is normal in up to 40 percent of Kingella kingae infections. CRP values tend to be higher in Staphylococcus aureus infections, especially MRSA, and higher levels are associated with complications such as abscess, bacteremia, and thrombosis, though specific cutoffs are not absolute. In summary, CRP is most useful for monitoring treatment response. It typically peaks two to four days after therapy initiation and declines rapidly with effective treatment, with a 50 percent reduction within four days seen in the majority of uncomplicated cases. Blood cultures should be obtained in all children with suspected osteomyelitis, ideally before starting antibiotics when feasible. In children, blood cultures alone can sometimes identify the pathogen. Plain radiographs are still recommended early, not because they're sensitive for acute osteomyelitis, but because they help exclude fracture, malignancy, or foreign body and establish a baseline. MRI with and without contrast is the preferred advanced imaging modality. MRI confirms the diagnosis, defines the extent of disease, and identifies complications such as subperiosteal abscess, physeal involvement, and concomitant septic arthritis. MRI findings can also guide the need for surgical consultation. Many pediatric centers now use FAST MRI protocols for suspected osteomyelitis, particularly from the emergency department. FAST MRI uses a limited sequence set, typically fluid-sensitive sequences like STIR or T2 with fat suppression, without contrast. These studies significantly reduce scan time, often avoid the need for sedation, and retain high sensitivity for bone marrow edema and soft tissue inflammation. FAST MRI is particularly useful when the clinical question is binary: is there osteomyelitis or not? It's most appropriate in stable children without high concern for abscess, multifocal disease, or surgical complications. If FAST MRI is positive, a full contrast-enhanced MRI may still be needed to delineate abscesses, growth plate involvement, or adjacent septic arthritis. If FAST MRI is negative but clinical suspicion remains high, further imaging may still be necessary. The Pediatric Infectious Diseases Society and the Infectious Diseases Society of America recommend empiric antibiotic selection based on regional MRSA prevalence, patient age, and illness severity, with definitive therapy guided by culture results and susceptibilities. Empiric therapy should never be delayed in an ill-appearing or septic child. In well-appearing, stable children, antibiotics may be briefly delayed to obtain imaging or tissue sampling, but this requires close inpatient observation. For children three months and older with non–life-threatening disease, empiric therapy hinges on local MRSA rates. In regions with low community-acquired MRSA prevalence, generally under 10 percent, reasonable empiric options include cefazolin, oxacillin, or nafcillin. When MRSA prevalence exceeds 10 to 20 percent, empiric therapy should include an MRSA-active agent. Clindamycin is appropriate when local resistance rates are low, while vancomycin is preferred when clindamycin resistance is common or the child has had significant healthcare exposure. For children with severe disease or sepsis, vancomycin is generally preferred regardless of local MRSA prevalence. Some experts recommend combining vancomycin with oxacillin or nafcillin to ensure optimal coverage for MSSA, group A streptococcus, and MRSA. In toxin-mediated or high-inoculum infections, the addition of clindamycin may be beneficial due to protein synthesis inhibition. Typical IV dosing includes cefazolin 100 to 150 milligrams per kilogram per day divided every eight hours; oxacillin or nafcillin 150 to 200 milligrams per kilogram per day divided every six hours; clindamycin 30 to 40 milligrams per kilogram per day divided every six to eight hours; and vancomycin 15 milligrams per kilogram every six hours for serious infections, with appropriate monitoring. Ceftaroline or daptomycin may be considered in select MRSA cases when first-line agents are unsuitable. For methicillin-susceptible Staphylococcus aureus, first-generation cephalosporins or antistaphylococcal penicillins remain the preferred parenteral agents. For oral therapy, high-dose cephalexin, 75 to 100 milligrams per kilogram per day divided every six hours, is preferred. Clindamycin is an alternative when beta-lactams cannot be used. For clindamycin-susceptible MRSA, clindamycin is the preferred IV and oral agent due to excellent bioavailability and bone penetration, and it avoids the renal toxicity associated with vancomycin. For clindamycin-resistant MRSA, vancomycin or ceftaroline are preferred IV agents. Oral options are limited, and linezolid is generally the preferred oral agent when transition is possible. Daptomycin may be used parenterally in children older than one year without pulmonary involvement, typically with infectious diseases and pharmacy input. Beta-lactams remain the drugs of choice for Kingella kingae, Streptococcus pyogenes, and Streptococcus pneumoniae. Vancomycin has no activity against Kingella, and clindamycin is often ineffective. For Salmonella osteomyelitis, typically seen in children with sickle cell disease, third-generation cephalosporins or fluoroquinolones are used. In underimmunized children under four years, consider Haemophilus influenzae type b, with therapy guided by beta-lactamase production. Doxycycline has not been prospectively studied in pediatric acute hematogenous osteomyelitis. There are theoretical concerns about reduced activity in infected bone and risks related to prolonged therapy. While short courses are safe for certain infections, the longer durations required for osteomyelitis increase the risk of adverse effects. Doxycycline should be considered only when no other active oral option is available, typically in older children, and with infectious diseases consultation. It is not appropriate for routine treatment. Many hospitals automatically consult orthopedics when children are admitted with osteomyelitis, and this is appropriate. Early orthopedic consultation should be viewed as team-based care, not failure of medical management. Consult orthopedics when MRI shows abscess or extensive disease, there is concern for septic arthritis, the child fails to improve within 48 to 72 hours, imaging suggests devitalized bone or growth plate involvement, there is a pathologic fracture, the patient is a neonate, or diagnostic bone sampling or operative drainage is being considered. Routine surgical debridement is not required for uncomplicated cases. Infectious diseases consultation is also often automatic and supported by guidelines. ID is particularly valuable for antibiotic selection, dosing, IV-to-oral transition, duration decisions, bacteremia management, adverse reactions, and salvage regimens. Even in straightforward cases, ID involvement often facilitates shorter IV courses and earlier oral transition. Osteomyelitis is generally not contagious, and clustering is uncommon for Staphylococcus aureus. Kingella kingae is the key exception. It colonizes the oropharynx of young children and spreads via close contact. Clusters of invasive Kingelladisease have been documented in daycare settings. Suspicion should be higher in children six to 36 months from the same daycare, with recent viral illness, mild systemic symptoms, refusal to bear weight, modest CRP elevation, and negative routine cultures unless PCR testing is used. Public health intervention is not typically required, but awareness is critical. There is no minimum required duration of IV therapy for uncomplicated acute hematogenous osteomyelitis. Transition to oral therapy should be based on clinical improvement plus CRP decline. Many children meet criteria within two to six days. Oral antibiotics must be dosed higher than standard outpatient regimens to ensure adequate bone penetration. Common regimens include high-dose cephalexin, clindamycin, or linezolid in select cases. The oral agent should mirror the IV agent that produced clinical improvement. Total duration is typically three to four weeks, and in many cases 15 to 20 days is sufficient. MRSA infections or complicated cases usually require four to six weeks. Early oral transition yields outcomes comparable to prolonged IV therapy with fewer complications. Most treatment-related complications occur during parenteral therapy, largely due to catheter-related issues. Take-home points: osteomyelitis in children is a clinical diagnosis supported by labs and MRI. Empiric antibiotics should be guided by age, illness severity, and local MRSA prevalence. Early transition to high-dose oral therapy is safe and effective when clinical response and CRP support it. Orthopedics and infectious diseases consultation improve care and reduce variation. FAST MRI is changing how we diagnose osteomyelitis. Daycare clustering is uncommon except with Kingella kingae. That's all for this episode. If there are other topics you'd like us to cover, let me know. If you have the time, leave a review on your favorite podcast platform. It helps more people find the show and learn from it. For PEM Currents, this has been Brad Sobolewski. See you next time.    

For this week's episode of the Clinician's Corner, we've gone into the archives to pull out another clinical pearl from one of our favorite episodes - and today we discuss beta glucuronidase and its surprisingly wide-ranging impact on our health (from hormones to gut health and even bone health).   This interview first aired earlier this year (2025), and the full interview can be viewed here.   Clinical pearls we extracted from the original interview: Understanding beta-glucuronidase (what it is and what it does) Challenging established views on beta glucuronidase Hormone-microbiome interactions Beta glucuronidase and GI function Clinical implications for women Gut-healing supplement recommendations  The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/   Connect with Dr. Betty Murray: Websites: https://bettymurray.com; https://livingwelldallas.com; ​​and https://getmenrva.com YouTube: https://www.youtube.com/@drbettymurray and https://www.youtube.com/@MenopauseMasteryShow Instagram: https://www.instagram.com/drbettymurray/ Facebook: https://www.facebook.com/drbettymurray LinkedIn: https://www.linkedin.com/in/bettymurray/   Timestamps:  00:00 "Microbiome Shifts with Hormones" 03:15 Microbiome, Hormones, and IBS Connections 06:26 Hormones, IBS, and Menopause Trends 10:21 "Fermented Foods and Intuition" 13:04 Clinician's Corner: Thank You   Speaker bio: Dr. Betty Murray is a women's health advocate, nutrition expert, PhD researcher, certified functional medicine practitioner, author, and speaker. Betty helps women over 40 harness their hormones to lose weight, optimize sleep, restore energy, and thrive. During her research for her Ph.D., Betty made several key discoveries that lead to hormone & metabolic imbalances that plague women over 40. Restoring balance to these key metabolic and hormone pathways is the basis of her Menopause Mastery Program.    Dr. Betty is the founder and CEO of Living Well Dallas Functional Medicine Center and Menrva, a national women's telemedicine company providing bioidentical hormone treatment, nutrition, diet, and lifestyle guidance to feel like perimenopause and menopause never happened. She is the host of the Menopause Mastery Podcast, author, and featured writer for Brainz Magazine. As a professional speaker, she has shared the stage with Lisa Nichols, Dr. Mark Hyman, JJ Virgin, Dr. Steven Gundry, Codie Sanchez, Dr. Shrini Pallay, and many others, and she is a frequently featured nutrition expert on Fox News Broadcasting, CW33, NBC, and CBS.     Keywords: functional health practitioners, beta glucuronidase, gut health, hormones, estrogen metabolism, microbiome, menopause, perimenopause, chronic disease, stool testing, IBS (Irritable Bowel Syndrome), serotonin receptors, neurotransmitters, glucuronidation, prostaglandins, GI motility, hormone cycles, case studies, evidence-based strategies, clinical pearls, hormone receptors, digestive supplements, fermented foods, polyphenols, resistant starches, gut healing protocols, 5R protocol, clinical training, restorative health, women's health Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.  

In episode 63 of Going anti-Viral, Dr Mari Kitahata joins host Dr Michael Saag to discuss the role of outcomes research on clinical decisions for patient care. Dr Kitahata is a Professor of Medicine at the University of Washington (UW) in the Division of Allergy and Infectious Diseases. For more than 3 decades, she has directed the UW/Fred Hutch Center for AIDS Research (CFAR) Clinical Research Core. Dr Kitahata's research focuses on improving long-term outcomes for people with HIV and she has led studies demonstrating key determinants of increased survival in people with HIV including early initiation of antiretroviral therapy and care managed by physicians with greater HIV experience. Dr Kitahata discusses the significance of outcomes research in clinical settings, particularly in the context of HIV care. She explains the differences between efficacy and effectiveness, the challenges faced in observational studies, and the importance of statistical techniques to address biases. Dr Kitahata and Dr Saag discuss the role of electronic medical records (EMRs) in enhancing data collection and the necessity of data validation through adjudication processes. Additionally, the conversation touches on the importance of patient-reported outcomes and the limitations of EMR data, including issues of misclassification. Finally, Dr Saag and Dr Kitahata discuss the distinction between predictive modeling and etiologic modeling in research, underscoring the complexities of clinical care and the future directions for outcomes research.0:00 – Introduction2:30 – Efficacy versus effectiveness5:51 – Challenges in outcomes research8:27 – Statistical techniques in observational studies16:13 – The role of electronic medical records19:36 – Patient-reported outcomes and their importance22:18 – Data validation and adjudication28:30 – Limitations of observational data35:08 – The future of outcomes research __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Summary This podcast episode features a comprehensive discussion with Dr. Ekama Carlson and Dr. Faranak Kamangar on the latest advancements in acne treatment, particularly focusing on energy-based devices and the innovative AvaClear laser. The speakers delve into the pathogenesis of acne, the effectiveness of various treatments, and the importance of patient selection for laser therapy. They also share insights from clinical trials and patient experiences, highlighting the transformative impact of these treatments on individuals suffering from acne. Takeaways - Acne affects 10% of the world's population, making it a significant dermatological issue. - Energy-based devices are becoming increasingly popular for managing acne. - Selecting the right patient for laser therapy is crucial for successful outcomes. - The Acne Laser Series protocol involves multiple treatments for optimal results. - AvaClear laser technology specifically targets sebaceous glands for effective acne treatment. - Clinical trials show promising results for the AvaClear laser in reducing inflammatory lesions. - Patient education about treatment expectations is essential for satisfaction. - Long-term outcomes of laser treatments can lead to significant improvements in skin health. - Innovations in dermatology are changing the landscape of acne treatment. - Combining treatments can enhance efficacy and patient satisfaction. Chapters 00:00 - Introduction to the Future of Dermatology Podcast 00:40 - Understanding Acne Pathogenesis and Treatments 01:52-  Energy-Based Devices for Acne Management 05:22 - Selecting Patients for Laser Therapy 06:40 - Acne Laser Series Protocol and Results 11:35 - Comparative Effectiveness of Treatments 15:05 - Innovations in Acne Treatment: The AvaClear Laser 19:18 - Clinical Trials and Efficacy of AvaClear 24:42 - Patient Experience and Long-Term Outcomes

Mentorship has become a buzzword in pelvic PT and OT — but most conversations around it are incomplete.In this episode, we break down the four distinct types of mentorship that actually shape clinical confidence, patient outcomes, and long-term career satisfaction. Most clinicians receive some mentorship — but very few receive all four.We unpack:Hard Skills Hands-on techniques, assessments, and interventions — what most people think of as “mentorship,” and what many con-ed courses focus on.Soft Skills Communication, motivation, managing difficult personalities, and helping patients truly buy into care. Often overlooked, but frequently the difference between average and exceptional outcomes.Information Understanding diagnoses, testing, medical management, and knowing what actually matters for the patient in front of you — not just what's theoretically interesting.Professional Development Career guidance, burnout prevention, time management, and mentorship that considers you as a person — not just a clinician.We also talk honestly about what to do if you're not getting this level of mentorship where you work — and how to approach your career strategically instead of hoping things improve on their own.

Research has been at the heart of NETRF's mission for 20 years—and patients are the reason that work matters. Every study we fund is designed to move the field forward and improve how people with neuroendocrine cancer live, feel, and are treated. In this special episode of NETWise, we're bringing the 2025 NETRF Neuroendocrine Cancer […] The post NETWise Episode 50: The Year in Review 2025: Neuroendocrine Cancer Research and Clinical Progress appeared first on NETRF.

With Joao Felipe Fernandes, King's College London, London - UK and Debbie Zhao, The University of Auckland, Auckland - New Zealand. Link to European Heart Journal paper Link to European Heart Journal editorial

Sobriety is hard—and recovery is a full-time job. Parenting is hard—and more than a full-time job. Sarah Allen Benton is an Advanced Alcohol and Drug Counselor and Licensed Mental Health Counselor. She is Chief Clinical Officer and co-owner of Waterview Behavioral Health. She is co-owner of Benton Behavioral Health Consulting, LLC, offering clinical and business support services to innovative addiction and mental health companies. She holds a Master of Science in Counseling Psychology with an emphasis in Health Psychology. Sarah has been sober for more than 20 years; she has been a mother for 13. She is far from alone, approximately 20.9 million consider themselves in recovery from a substance use disorder (SUD). It is fair to say millions are also parents. In PARENTS IN RECOVERY: Navigating a Sober Family Lifestyle (Rowman & Littlefield), Sarah draws on research, professional expertise and deeply personal experience to support mothers and fathers as they navigate their way through parenting while embracing a sober lifestyle. From “wine mom culture” to social media FOMO, Benton covers every aspect of living sober while raising children. Amazon: Parents in Recovery: Parents in Recovery: Navigating a Sober Family Lifestyle Understanding the High-Functioning Alcoholic: https://www.amazon.com/Underst... Facebook: https://www.facebook.com/sarah... Parents in Recovery Support Group Facebook: https://www.facebook.com/share... Linked In: https://www.linkedin.com/in/sa... Instagram - @parentsinrecovery Website:www.bentonbhc.comwww.waterviewbh.com Sarah Allen Benton, M.S., LMHC, CADC, is a leading authority in addiction and mental health, known for her clinical expertise and published work. As an Advanced Alcohol and Drug Counselor (CADC) and Licensed Mental Health Counselor (LMHC), she brings over 20 years of lived experience as a parent in recovery from alcohol use disorder to her practice. Clinical and Business Leadership Chief Clinical Officer & Co-founder: Sarah Allen Benton is the CCO and co-founder of Waterview Behavioral Health (Wallingford, CT), a specialized mental health intensive outpatient program (IOP) providing crucial services for individuals with complex needs. Website: https://www.waterviewbh.com/ Co-owner: She is also the co-owner of Benton Behavioral Health Consulting, LLC, which offers clinical and business support services, including strategic consulting, to innovative mental health and addiction companies across the industry. Website: https://www.bentonbhc.com/ Expertise: Her background includes roles as a therapist and clinical consultant across various levels of care, practices, and start-ups, including experience at McLean Hospital in their dual diagnosis transitional treatment program. Published Work and Education Author: Benton is the highly-regarded author of Understanding the High-Functioning Alcoholic (2009), a foundational text that provides insight into high-achieving individuals struggling with alcohol use disorder, a common area of her expertise. Education: She holds a Master of Science in Counseling Psychology with an emphasis in Health Psychology from Northeastern University, Bouvé School of Health Sciences. Location and Credentials Location: Killingworth, Connecticut Credentials: M.S., LMHC, CADC This profile emphasizes her dual role as a clinical expert and a behavioral health entrepreneur, making her a highly discoverable authority in addiction recovery, sober parenting, and high-functioning alcoholism treatment. Meet Ash Brown, the dynamic American powerhouse and motivational speaker dedicated to fueling your journey toward personal and professional success. Recognized as a trusted voice in personal development, Ash delivers uplifting energy and relatable wisdom across every platform. Why Choose Ash? Ash Brown stands out as an influential media personality due to her Authentic Optimism and commitment to providing Actionable Strategies. She equips audiences with the tools necessary to create real change and rise above challenges. Seeking inspiration? Ash Brown is your guide to turning motivation into measurable action. The Ash Said It Show – Top-Ranked Podcast With over 2,100 episodes and 700,000+ global listens, Ash's podcast features inspiring interviews, life lessons, and empowerment stories from changemakers across industries. Each episode delivers practical tools and encouragement to help listeners thrive. Website: AshSaidit.com Connect with Ash Brown: Goli Gummy Discounts: https://go.goli.com/1loveash5 Luxury Handbag Discounts: https://www.theofficialathena.... Review Us: https://itunes.apple.com/us/po... Subscribe on YouTube: http://www.youtube.com/c/AshSa... Instagram: https://www.instagram.com/1lov... Facebook: https://www.facebook.com/ashsa... Blog: http://www.ashsaidit.com/blog #atlanta #ashsaidit #theashsaiditshow #ashblogsit #ashsaidit®Become a supporter of this podcast: https://www.spreaker.com/podcast/ash-said-it-show--1213325/support.

This is a fan fav episode. When you think of cultural beliefs, how often have you found yourself questioning where these beliefs stem from? My guest today explores the notion of cultural lies that are at the root of our suffering as a society and as individuals. Clinical psychologist, Dr. Shefali shares some of her most profound insights from her latest book, A Radical Awakening. Witness her working through some ideas with me in real time around the culture being the villain versus owning your internal life and consciousness. Dive into some of the deeper ideas Dr Shefali presents starting with recognizing our destructive animal nature. Order Dr. Shefali's book, A Radical Awakening: ⁠https://www.aradicalawakening.com/⁠  Original air date: 6-22-2021 SHOW NOTES: 0:00 | Introduction to Dr. Shefali 2:16 | Layers of Radical Awakening 3:29 | Our Animal Nature & Biological Wiring 8:06 | Our Destructive Nature to Justify 9:42 | Learn To Be Interconnected in Consciousness 13:50 | Chasing Dominance & Delusional Cravings 16:13 | Insecurities & Endless Consumerism 18:51 | Women Not Fitting The Beauty Standard 22:19 | Learning to Accept Yourself 25:32 | Dr. Shefali Explains the Toxic Patriarchy 33:20 | Women Buffering Against the Patriarchal System 36:36 | The Effects of Unconsciousness of Culture 39:57 | Who is Culture? What Toxicity Are You Buying? 41:35 | Navigating the Toxic Beliefs From Culture 44:05 | Dr. Shefali on Cultivating Your Own Voice 47:51 | Awakening to The Marriage Contract 52:07 | The Lie of Monogamy in Culture 53:28 | Our Insecurity That Drives Domination 54:51 | Realizing Self Worth and Self Acceptance  Learn more about your ad choices. Visit megaphone.fm/adchoices

In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss the rise in norovirus infections, contamination of infant formula and botulism outbreak, confusion and response to the CDC's ACIP decision to reverse the recommendation for a birth dose of the hepatis B virus vaccine and how states in the Northwest and Northeast are responding as well as some insurance companies, then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, South Carolina's imposed quarantine of individuals due to their accelerated measles outbreak, neurotropism of H1N1, benefits of the RSV and COVID vaccines, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Norovirus season! (Wastewater Scan) Outbreak Investigation of Infant Botulism: Infant Formula (November 2025) (FDA: Foodborne illnesses) Botulism outbreak sickens more than 50 babies and expands to all ByHeart products (AP News) CDC advisers drop decades-old universal hepatitis B birth dose recommendation, suggest blood testing after 1 dose (CIDRAP) Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program — United States, 1994–2023 (CDC: MMWR) Universal Hepatitis B vaccination at birth: safety, effectiveness and public health impact (CIDRAP) Recommended Child and Adolescent Immunization Schedule for Ages 18 years or younger (American Academy of Pediatrics) West Coast health experts reject RFK Jr. panel, say hepatitis B vaccines at birth should continue (The Oregonian) Statement from the Northeast Public Health Collaborative In Response to ACIP's Hepatitis B Vote (NJ.Gov Health) Governors Denounce ACIP Recommendation on Hepatitis B Vaccination, Reaffirm Commitment to Strong, Evidence-Based Childhood Vaccination Programs (Governors Public Health Alliance) Blue Cross and Blue Shield Companies Statement on Vaccines (Blue Cross Blue Shield) AHIPStatement on Vaccine Coverage (AHIP) Pediatricians reject CDC advisers' guidance, plan to continue vaccinating all newborns against hepatitis B (CIDRAP) Survey: Social media on par with CDC as trusted vaccine source (Healio) FDA to investigate whether adult deaths linked to COVID vaccine (Washington Post) Exclusive: US FDA launches fresh safety scrutiny of approved RSV therapies for infants (Reuters) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Contemporary highly pathogenic avian influenza (H5N1) viruses retain neurotropism in human cerebral organoids (OFID) Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks (USDA: Animal and Plant Health Inspection Service) Indiana, cases of New World screwworm in Mexico, rising US flu activity (CIDRAP) Mexico reports 92 cases of myiasis in humans caused by screwworm (Expreso.press) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Hundreds quarantined as South Carolina measles outbreak accelerates (Washington Post) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) ACIP Recommendations Summary (CDC: Influenza) Types of Influenza Viruses (CDC: Influenza (flu)) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Intensive Care Unit Stay and Mechanical Ventilation Among Adults with Respiratory Syncytial Virus-Related Hospitalization by Age and Comorbidity Status (Infectious Diseases and Therapy) Cardiovascular Events 1 Year After Respiratory Syncytial Virus Infection in Adults (JAMA: Open Network) Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease, United States, February 2022–September 2023 (CDC: Emerging Infectious Diseases) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis (LANCET: Infectious Diseases) Effectiveness of Nirsevimab in Preventing Respiratory Syncytial Virus-related Burden: A Test-negative Case-control Study in Infants With Bronchiolitis in Lombardy Region, Italy (The Pediatric Infectious Disease Journal) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy (Obstetrics & Gynecology) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France (JAMA: Open Network) Two-year prognosis of mRNA vaccine-related myocarditis compared with historical conventional myocarditis: a population-based cohort study (CMI: Clinical Microbiology and Infection) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1278 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Conor McNamara joins Ian Dennis & Ali Bruce-Ball to talk travel, football and language. Ian & Conor give their take on Salah after the drama unfolded with them at Elland Road. They look ahead to the Wear-Tyne derby, it's Ali vs Ian in Clash of the Commentators, there are yet more unintended pub names, and which commentary phrases will end up in our Great Glossary? Suggestions welcome on WhatsApp voicenotes to 08000 289 369 & emails to TCV@bbc.co.uk00:35 Why we all love San Siro 04:10 The Bruges or Brugge debate returns 07:15 Salah story unfolds with Ian & Conor 09:20 Has Salah played his last game for Liverpool? 16:25 John Murray's message from Madrid 20:45 Wear-Tyne derby among Premier League commentaries 27:05 Unintended pub names 40:20 Clash of the Commentators 46:35 Great Glossary of Football Commentary5 Live / BBC Sounds Premier League commentaries: Sat 1500 Liverpool v Brighton, Sat 1500 Chelsea v Everton on Sports Extra, Sat 1730 Burnley v Fulham, Sun 1400 Sunderland v Newcastle, Sun 1400 Crystal Palace v Man City on Sports Extra, Sun 1400 Nottingham Forest v Tottenham on Sports Extra 2, Sun 1400 West Ham v Aston Villa on Sports Extra 3, Sun 1630 Brentford v Leeds.Glossary so far (in alphabetical order):DIVISION ONE Bosman, Couldn't sort their feet out, Cruyff Turn, Dead-ball specialist, Fox in the box, Giving the goalkeeper the eyes, Head tennis, Hibs it, In a good moment, The Maradona, Off their line, Olimpico, Onion bag, Panenka, Perfect hat-trick, Points to the spot, Rabona, Schmeichel-style, Scorpion kick, Spursy, Tiki-taka, Where the kookaburra sleeps, Where the owl sleeps, Where the spiders sleep. DIVISION TWO Ball stays hit, Business end, Came down with snow on it, Catching practice, Camped in the opposition half Cauldron atmosphere Coat is on a shoogly peg, Come back to haunt them, Corridor of uncertainty, Easy tap-in, Daisy-cutter, First cab off the rank, Good leave, Half-turn, Has that in his locker, High wide and not very handsome, Hospital pass, Howler, In their pocket, Johnny on the spot, Leading the line, Nutmeg, One for the cameras, One for the purists, Played us off the park, Purple patch, Put their laces through it, Rolls Royce, Root and branch review, Row Z, Screamer, Seats on the plane, Show across the bows, Slide-rule pass, Steal a march, Stramash, Taking one for the team, Telegraphed that pass, That's great… (football), Thunderous strike, Walk it in. UNSORTED 2-0 is a dangerous score, After you Claude, All-Premier League affair, Aplomb, Bag/box of tricks, Brace, Brandished, Bread and butter, Breaking the deadlock, Bundled over the line, Champions elect / champions apparent, Clinical finish, Commentator's curse, Coupon buster, Cultured/Educated left foot, Denied by the woodwork, Draught excluder, Elimination line, Fellow countryman, Foot race, Formerly of this parish, Free hit, Goalkeepers' Union, Goalmouth scramble, Good touch for a big man, Honeymoon Period, In and around, In the shop window, Keeping ball under their spell, Keystone Cops defending, Languishing, Loitering with intent, Marching orders, Nestle in the bottom corner, Numbered derbies, Opposite number, Park the bus, PK for penalty-kick, Postage stamp, Put it in the mixer, Rasping shot, Red wine not white wine, Relegation six-pointer, Rooted at the bottom, Route One, Roy of the Rovers stuff, Sending the goalkeeper the wrong way, Shooting boots, Sleeping giants, Slide rule pass, Small matter of, Spiders web, Stayed hit, Steepling, Stinging the palms, Stonewall penalty, Straight off the training ground, Taking one for the team, Team that likes to play football, Throw their cap on it, Thruppenny bit head / 50p head, Towering header, Two good feet, Turning into a basketball match, Turning into a cricket score, Usher/Shepherd the ball out of play, Walking a disciplinary tightrope, Wand of a left foot, We've got a cup tie on our hands, Wrap foot around it, Your De Bruynes, your Gundogans etc.

Hallucinations are the most recognized—and most misunderstood—symptom of schizophrenia. Movies depict them as dramatic, terrifying commands or cinematic visions, but the lived reality is far more complex. In this episode we unravel what hallucinations actually are, why they happen, and how people learn to live with them. This episode is a special feature from our sister show Inside Schizophrenia. Hosted by Rachel Star Withers (who lives with schizophrenia), with Gabe Howard as co-host. (Don't worry, new Inside Mental Health episodes return in 2026.) In this episode, Rachel shares her own experiences, from everyday “simple” hallucinations like sounds or shifting faces, to more intense, emotion-laden complex hallucinations. She challenges the assumption that hallucinations are always violent or dangerous—and breaks down the critical differences between hallucinations and sensory disturbances. Expert guest Dr. Paul Fitzgerald joins the conversation to explain how the brain creates these perceptual misfires, why hallucinations in schizophrenia differ from those caused by grief, sleep deprivation, or drugs, and what current research reveals about how universal these experiences are across different cultures and countries. Listener Takeaways The difference between simple vs. complex hallucinations Why hallucinations in schizophrenia feel different from drug- or grief-based ones Why reducing—not eliminating—hallucinations is often the realistic recovery goal How CBT and coping strategies help reduce fear and regain control Whether you live with schizophrenia, love someone who does, or are simply curious about how the brain works, this episode offers clarity, compassion, and surprising insights you won't forget. Guest, Professor Paul Fitzgerald, completed his medical degree at Monash University and subsequently a Master of Psychological Medicine whilst completing psychiatric training. He then undertook a Clinical and Research Fellowship at the University of Toronto and The Clarke Institute of Psychiatry, Toronto, Ontario, Canada. On returning to Melbourne, he worked as a psychiatrist and completed a PhD in transcranial magnetic stimulation in schizophrenia. Since completing this PhD, he has developed a substantial research program including a team of over 25 psychiatrists, registrars, postdoctoral researchers, research assistants, research nurses, and students. Professor Fitzgerald runs a research program across both MAPrc and Epworth Clinic using brain stimulation and neuroimaging techniques including transcranial magnetic stimulation, functional and structural MRI, EEG, and near infrared spectroscopy.  The primary focus of this program is on the development of new brain stimulation-based treatments for psychiatric disorders. Guest host, Rachel Star Withers, creates videos documenting her schizophrenia, ways to manage, and let others like her know they're not alone and can still live an amazing life. She has written “Lil Broken Star: Understanding Schizophrenia for Kids” and a tool for schizophrenics, “To See in the Dark: Hallucination and Delusion Journal.” Learn more at RachelStarLive.com. Our host, Gabe Howard, is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. Gabe is also the host of the "Inside Bipolar" podcast with Dr. Nicole Washington. Gabe makes his home in the suburbs of Columbus, Ohio. He lives with his supportive wife, Kendall, and a Miniature Schnauzer dog that he never wanted, but now can't imagine life without. To book Gabe for your next event or learn more about him, please visit gabehoward.com. Learn more about your ad choices. Visit megaphone.fm/adchoices